Released May 10, 2013, after the close
10-Q filed May 10, 2013, 40 days after period end · 0001144204-13-027924
Q1 2013 · 10-Q
Revenue—
Net Income-$3.72M-$3.72M N/M vs Q1 2012N/M vs Q4 2012
EPS Diluted-$0.22-$0.22 N/M vs Q1 2012N/M vs Q4 2012
Operating Income-$3,768,968N/M
Operating Cash Flow-$4,370,119N/M
Free Cash Flowderived-$4,370,119—
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|
| Net Income | -$3.72M | -$8.17M | -$2.72M |
| EPS Diluted | -$0.22 | -$0.66 | -$0.38 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Assembly Biosciences, Inc. · CIK 1426800 · Engraved from SEC EDGAR